209 related articles for article (PubMed ID: 32505732)
1. Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.
Zhao E; Zhou C; Chen S
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101455. PubMed ID: 32505732
[TBL] [Abstract][Full Text] [Related]
2. Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer.
Zhu C; Xiao D
Medicine (Baltimore); 2020 Nov; 99(47):e23133. PubMed ID: 33217815
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma.
Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z
Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086
[TBL] [Abstract][Full Text] [Related]
4. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.
Abdel-Fatah TM; Russell R; Albarakati N; Maloney DJ; Dorjsuren D; Rueda OM; Moseley P; Mohan V; Sun H; Abbotts R; Mukherjee A; Agarwal D; Illuzzi JL; Jadhav A; Simeonov A; Ball G; Chan S; Caldas C; Ellis IO; Wilson DM; Madhusudan S
Mol Oncol; 2014 Oct; 8(7):1326-38. PubMed ID: 24880630
[TBL] [Abstract][Full Text] [Related]
5. Validation of CDC45 as a novel biomarker for diagnosis and prognosis of gastric cancer.
Wu L; Gao G; Mi H; Luo Z; Wang Z; Liu Y; Wu L; Long H; Shen Y
PeerJ; 2024; 12():e17130. PubMed ID: 38515458
[TBL] [Abstract][Full Text] [Related]
6. Flap endonuclease 1 is a promising candidate biomarker in gastric cancer and is involved in cell proliferation and apoptosis.
Wang K; Xie C; Chen D
Int J Mol Med; 2014 May; 33(5):1268-74. PubMed ID: 24590400
[TBL] [Abstract][Full Text] [Related]
7. Analysis and application of RNA binding protein gene pairs to predict the prognosis of gastric cancer.
Ning ZK; Tian HK; Liu J; Hu CG; Liu ZT; Li H; Zong Z
Heliyon; 2023 Jul; 9(7):e18242. PubMed ID: 37539127
[TBL] [Abstract][Full Text] [Related]
8. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic insights into FEN1-mediated drug sensitivity and risk signature in colon cancer: An integrative bioinformatics study.
Rao C; Tong J; Yang Y
Medicine (Baltimore); 2024 Mar; 103(13):e37517. PubMed ID: 38552056
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
[No Abstract] [Full Text] [Related]
11. High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer.
Zhao Z; Li S; Li S; Wang J; Lin H; Fu W
Cancer Cell Int; 2021 Sep; 21(1):493. PubMed ID: 34530820
[TBL] [Abstract][Full Text] [Related]
12. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.
Lin Y; Zhang L; Zhang X; Wei X; Liu X; Xie Y; Han G
J Environ Pathol Toxicol Oncol; 2023; 42(4):61-68. PubMed ID: 37522568
[TBL] [Abstract][Full Text] [Related]
13. Glucoside xylosyltransferase 2 as a diagnostic and prognostic marker in gastric cancer via comprehensive analysis.
Zhao Y; Hu S; Zhang J; Cai Z; Wang S; Liu M; Dai J; Gao Y
Bioengineered; 2021 Dec; 12(1):5641-5654. PubMed ID: 34506251
[TBL] [Abstract][Full Text] [Related]
14. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlations and prognostic value of Nudix hydroxylase 10 in patients with gastric cancer.
Chen D; Zhang R; Xie A; Yuan J; Zhang J; Huang Y; Zhang H; Zhang F
Bioengineered; 2021 Dec; 12(2):9779-9789. PubMed ID: 34696672
[TBL] [Abstract][Full Text] [Related]
16. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
17. A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.
Zhao E; Zhou C; Chen S
Clin Transl Oncol; 2021 Feb; 23(2):265-274. PubMed ID: 32519178
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
19. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
20. High Expression of Retinoic Acid Induced 14 (RAI14) in Gastric Cancer and Its Prognostic Value.
He XY; Zhao J; Chen ZQ; Jin R; Liu CY
Med Sci Monit; 2018 Apr; 24():2244-2251. PubMed ID: 29654694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]